Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Exozymes Inc.

NASDAQ: EXOZ · Life Sciences · 4 alerts · CIK 2010788

Share price
$3.99Close, Nov 16
Market cap
$37.7M
Shares outstanding
9.44MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Exozymes Inc. filings on SEC EDGAR ↗

3:59 PM ET 10-Q
Financial Results

Exozymes Q3 2026 Results: Net Loss of $2.24M, Loss Narrows

EXOZYMES INC. reported a net loss of $7.49 million for the nine months ended September 30, 2026, compared to a $6.50 million loss in the prior year. The company remains in a development stage with no operating income, primarily funded by a public offering and registered direct offering that raised approximately $5.86 million in net proceeds during the period.

Key figure
Net loss $2.24M
3:01 PM ET Form 4
Insider Selling

Exozymes Chief Commercial Officer Damien Alan Perriman Sells $19.4K of Stock

Damien Alan Perriman, Chief Commercial Officer, sold 3,729 shares of Exozymes Inc. at $5.21 a share, worth $19.4K in total on Oct 12, 2026. Shares held after the trade: 28,692 (-11.5%).

Value
$19.4K
Shares
3,729
Price
$5.21
Role
Chief Commercial Officer
Holding change
-11.5%
Trade date
Oct 12, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.